|View printer-friendly version|
|February 07, 2011 4:51 p.m.|
|Teva Invites Public to Listen to Its 2011 Investor Meeting Webcast|
|Jerusalem, Israel, February 7, 2011 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) invites investors and the general public to listen to a live audio webcast of its 2011 Investor Meeting on Wednesday, February 9, 2011 at 3:00 p.m. ET.|
What: Teva's 2011 Investor Meeting
Who: Teva Management
When: Wednesday, February 9, 2011 at 3:00 p.m. ET
Where: www.tevapharm.com/financial/ or
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs approximately 40,000 people around the world and reached $13.9 billion in net sales in 2009.